These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 19496748)

  • 1. In situ gelling polymers in ocular drug delivery systems: a review.
    Mundada AS; Avari JG
    Crit Rev Ther Drug Carrier Syst; 2009; 26(1):85-118. PubMed ID: 19496748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ-forming hydrogels for sustained ophthalmic drug delivery.
    Nanjawade BK; Manvi FV; Manjappa AS
    J Control Release; 2007 Sep; 122(2):119-34. PubMed ID: 17719120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Situ Gelling Ophthalmic Drug Delivery System: An Overview and Its Applications.
    Sheshala R; Kok YY; Ng JM; Thakur RR; Dua K
    Recent Pat Drug Deliv Formul; 2015; 9(3):237-48. PubMed ID: 26205681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advancement in stimuli triggered in situ gelling delivery for local and systemic route.
    Ajazuddin ; Alexander A; Khan J; Giri TK; Tripathi DK; Saraf S; Saraf S
    Expert Opin Drug Deliv; 2012 Dec; 9(12):1573-92. PubMed ID: 23075325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained ocular delivery of brimonidine tartrate using ion activated in situ gelling system.
    Geethalakshmi A; Karki R; Jha SK; Venkatesh DP; Nikunj B
    Curr Drug Deliv; 2012 Mar; 9(2):197-204. PubMed ID: 22283647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ gel systems as 'smart' carriers for sustained ocular drug delivery.
    Agrawal AK; Das M; Jain S
    Expert Opin Drug Deliv; 2012 Apr; 9(4):383-402. PubMed ID: 22432690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system.
    Gupta H; Jain S; Mathur R; Mishra P; Mishra AK; Velpandian T
    Drug Deliv; 2007 Nov; 14(8):507-15. PubMed ID: 18027180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in ocular drug delivery.
    Achouri D; Alhanout K; Piccerelle P; Andrieu V
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ophthalmic controlled release in situ gelling systems for ciprofloxacin based on polymeric carriers.
    Al-Kassas RS; El-Khatib MM
    Drug Deliv; 2009 Apr; 16(3):145-52. PubMed ID: 19514974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terminalia arjuna gum/alginate in situ gel system with prolonged retention time for ophthalmic drug delivery.
    Noreen S; Ghumman SA; Batool F; Ijaz B; Basharat M; Noureen S; Kausar T; Iqbal S
    Int J Biol Macromol; 2020 Jun; 152():1056-1067. PubMed ID: 31751751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and evaluation of thermoreversible in situ gelling system of forskolin for the treatment of glaucoma.
    Gupta S; Samanta MK
    Pharm Dev Technol; 2010; 15(4):386-93. PubMed ID: 19772380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular application of chitosan.
    Başaran E; Yazan Y
    Expert Opin Drug Deliv; 2012 Jun; 9(6):701-12. PubMed ID: 22530690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH- and ion-sensitive polymers for drug delivery.
    Yoshida T; Lai TC; Kwon GS; Sako K
    Expert Opin Drug Deliv; 2013 Nov; 10(11):1497-513. PubMed ID: 23930949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan-Based In Situ Gels for Ocular Delivery of Therapeutics: A State-of-the-Art Review.
    Irimia T; Dinu-Pîrvu CE; Ghica MV; Lupuleasa D; Muntean DL; Udeanu DI; Popa L
    Mar Drugs; 2018 Oct; 16(10):. PubMed ID: 30304825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymer-based carriers for ophthalmic drug delivery.
    Imperiale JC; Acosta GB; Sosnik A
    J Control Release; 2018 Sep; 285():106-141. PubMed ID: 29964135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent developments in ocular drug delivery.
    Chen H
    J Drug Target; 2015; 23(7-8):597-604. PubMed ID: 26453157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polysaccharide as renewable responsive biopolymer for in situ gel in the delivery of drug through ocular route.
    Chowhan A; Giri TK
    Int J Biol Macromol; 2020 May; 150():559-572. PubMed ID: 32057864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potential nanoparticle-loaded in situ gel for enhanced and sustained ophthalmic delivery of dexamethasone.
    Wen Y; Ban J; Mo Z; Zhang Y; An P; Liu L; Xie Q; Du Y; Xie B; Zhan X; Tan L; Chen Y; Lu Z
    Nanotechnology; 2018 Oct; 29(42):425101. PubMed ID: 30074486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermo-responsive systems for controlled drug delivery.
    Bikram M; West JL
    Expert Opin Drug Deliv; 2008 Oct; 5(10):1077-91. PubMed ID: 18817514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketoroloac tromethamine loaded nanodispersion incorporated into thermosensitive in situ gel for prolonged ocular delivery.
    Morsi N; Ghorab D; Refai H; Teba H
    Int J Pharm; 2016 Jun; 506(1-2):57-67. PubMed ID: 27091293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.